MA23606A1 - Procede de preparation du trihydrate du (2r, 3s) -3-tert-butoxycarbonylamino -2-hydroxy-3- phenylpropionate de 4-acetoxy-2a- benzoyloxy-5b , 20-epoxy-1.7b, 10b- trihydroxy- 9- oxo-tax-11- en-13 a-yle. - Google Patents

Procede de preparation du trihydrate du (2r, 3s) -3-tert-butoxycarbonylamino -2-hydroxy-3- phenylpropionate de 4-acetoxy-2a- benzoyloxy-5b , 20-epoxy-1.7b, 10b- trihydroxy- 9- oxo-tax-11- en-13 a-yle.

Info

Publication number
MA23606A1
MA23606A1 MA23945A MA23945A MA23606A1 MA 23606 A1 MA23606 A1 MA 23606A1 MA 23945 A MA23945 A MA 23945A MA 23945 A MA23945 A MA 23945A MA 23606 A1 MA23606 A1 MA 23606A1
Authority
MA
Morocco
Prior art keywords
beta
butoxycarbonylamino
benzoyloxy
tax
acetoxy
Prior art date
Application number
MA23945A
Other languages
English (en)
French (fr)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA23606(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MA23606A1 publication Critical patent/MA23606A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MA23945A 1994-07-08 1995-07-06 Procede de preparation du trihydrate du (2r, 3s) -3-tert-butoxycarbonylamino -2-hydroxy-3- phenylpropionate de 4-acetoxy-2a- benzoyloxy-5b , 20-epoxy-1.7b, 10b- trihydroxy- 9- oxo-tax-11- en-13 a-yle. MA23606A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9408479A FR2722191B1 (fr) 1994-07-08 1994-07-08 Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle

Publications (1)

Publication Number Publication Date
MA23606A1 true MA23606A1 (fr) 1996-04-01

Family

ID=9465183

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23945A MA23606A1 (fr) 1994-07-08 1995-07-06 Procede de preparation du trihydrate du (2r, 3s) -3-tert-butoxycarbonylamino -2-hydroxy-3- phenylpropionate de 4-acetoxy-2a- benzoyloxy-5b , 20-epoxy-1.7b, 10b- trihydroxy- 9- oxo-tax-11- en-13 a-yle.

Country Status (38)

Country Link
US (1) US6022985A (enExample)
EP (1) EP0770070B1 (enExample)
JP (1) JP3753155B2 (enExample)
KR (1) KR100391753B1 (enExample)
CN (1) CN1067996C (enExample)
AT (1) ATE171702T1 (enExample)
AU (1) AU706519B2 (enExample)
BR (1) BR9508789A (enExample)
CA (1) CA2193531C (enExample)
CO (1) CO4410189A1 (enExample)
CZ (1) CZ284695B6 (enExample)
DE (1) DE69505128T2 (enExample)
DK (1) DK0770070T3 (enExample)
DZ (1) DZ1905A1 (enExample)
ES (1) ES2121404T3 (enExample)
FI (1) FI119246B (enExample)
FR (1) FR2722191B1 (enExample)
GR (1) GR3027558T3 (enExample)
HU (1) HU220634B1 (enExample)
IL (1) IL114274A (enExample)
IN (1) IN183947B (enExample)
IS (1) IS2032B (enExample)
MA (1) MA23606A1 (enExample)
MX (1) MX9700173A (enExample)
MY (1) MY118481A (enExample)
NO (1) NO314500B1 (enExample)
NZ (1) NZ289455A (enExample)
PE (1) PE8697A1 (enExample)
PL (1) PL179876B1 (enExample)
RU (1) RU2126397C1 (enExample)
SI (1) SI0770070T1 (enExample)
SK (1) SK280520B6 (enExample)
TN (1) TNSN95071A1 (enExample)
TW (1) TW419473B (enExample)
UA (1) UA51624C2 (enExample)
UY (1) UY23991A1 (enExample)
WO (1) WO1996001815A1 (enExample)
ZA (1) ZA955646B (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU753781B2 (en) 1997-04-28 2002-10-31 Aventis Pharma S.A. Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
US6853921B2 (en) 1999-07-20 2005-02-08 Halliburton Energy Services, Inc. System and method for real time reservoir management
US6266619B1 (en) * 1999-07-20 2001-07-24 Halliburton Energy Services, Inc. System and method for real time reservoir management
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US7584165B2 (en) * 2003-01-30 2009-09-01 Landmark Graphics Corporation Support apparatus, method and system for real time operations and maintenance
US8703982B2 (en) 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
EP1947094A3 (en) 2003-12-12 2009-02-18 Quiral Quimica Do Brasil Process for the preparation of taxane derivatives
US7142986B2 (en) * 2005-02-01 2006-11-28 Smith International, Inc. System for optimizing drilling in real time
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
CN101291658B (zh) 2005-08-31 2014-04-16 阿布拉科斯生物科学有限公司 用于制备稳定性增加的水难溶性药物的组合物和方法
US7771751B2 (en) 2005-08-31 2010-08-10 Abraxis Bioscience, Llc Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
WO2007044950A2 (en) * 2005-10-12 2007-04-19 Sicor, Inc. Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
WO2007084611A2 (en) * 2006-01-20 2007-07-26 Landmark Graphics Corporation Dynamic production system management
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
EP2330101A1 (en) * 2006-10-20 2011-06-08 Scinopharm Singapore Pte, Ltd. Process for making crystalline docetaxel
KR100868116B1 (ko) * 2007-04-09 2008-11-10 한미약품 주식회사 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법
KR100878455B1 (ko) 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
WO2009006590A2 (en) * 2007-07-04 2009-01-08 Dr. Reddy's Laboratories Ltd. Docetaxel process and polymorphs
EP2080763A1 (en) * 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
EP2080764B1 (en) 2008-01-18 2012-08-22 INDENA S.p.A. Solid forms of ortataxel
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
US8686165B2 (en) * 2009-11-04 2014-04-01 Emcure Pharmaceuticals Limited Process for preparation of taxane derivatives
JP5824511B2 (ja) 2010-05-03 2015-11-25 テイコク ファーマ ユーエスエー インコーポレーテッド 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
ES2704632T3 (es) 2011-09-08 2019-03-19 Univ New York Virus de herpes simplex oncolítico y sus usos terapéuticos
US9745631B2 (en) 2011-12-20 2017-08-29 Dana-Farber Cancer Institute, Inc. Methods for diagnosing and treating oncogenic kras-associated cancer
EP2833905B1 (en) 2012-04-04 2018-05-02 Halozyme, Inc. Combination therapy with hyaluronidase and a tumor-targeted taxane
AU2013266243A1 (en) 2012-05-24 2014-12-18 Beth Israel Deaconess Medical Center, Inc. Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
WO2014014518A1 (en) 2012-07-18 2014-01-23 Dana-Farber Cancer Institute, Inc. Methods for treating, preventing and predicting risk of developing breast cancer
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US10238723B2 (en) 2013-03-14 2019-03-26 Icahn School Of Medicine At Mount Sinai Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
WO2015050844A1 (en) 2013-10-01 2015-04-09 Dana-Farber Cancer Institute, Inc. Methods of treating cancer with atovaquone-related compounds
WO2015149006A2 (en) 2014-03-27 2015-10-01 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
MA39818A (fr) 2014-03-30 2017-02-08 Benevir Biopharm Inc Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
EP3307330B1 (en) 2015-06-15 2021-03-10 New York University Method of treatment using oncolytic viruses
WO2019222435A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
IL114274A0 (en) 1995-10-31
FI119246B (fi) 2008-09-15
BR9508789A (pt) 1997-10-21
UA51624C2 (uk) 2002-12-16
DK0770070T3 (da) 1999-03-01
SK280520B6 (sk) 2000-03-13
NO970007D0 (no) 1997-01-02
PL179876B1 (pl) 2000-11-30
DE69505128T2 (de) 1999-04-01
TNSN95071A1 (fr) 1996-02-06
DZ1905A1 (fr) 2002-02-17
MY118481A (en) 2004-11-30
KR100391753B1 (ko) 2004-02-11
IL114274A (en) 1999-04-11
UY23991A1 (es) 1995-09-20
CO4410189A1 (es) 1997-01-09
FR2722191A1 (fr) 1996-01-12
HU9700041D0 (en) 1997-02-28
CA2193531C (fr) 2006-12-05
CN1151741A (zh) 1997-06-11
FI970069L (fi) 1997-01-07
CZ3597A3 (en) 1997-04-16
FI970069A0 (fi) 1997-01-07
MX9700173A (es) 1997-04-30
WO1996001815A1 (fr) 1996-01-25
CN1067996C (zh) 2001-07-04
JPH10502627A (ja) 1998-03-10
KR970704721A (ko) 1997-09-06
ES2121404T3 (es) 1998-11-16
ATE171702T1 (de) 1998-10-15
IN183947B (enExample) 2000-05-20
AU2930595A (en) 1996-02-09
JP3753155B2 (ja) 2006-03-08
AU706519B2 (en) 1999-06-17
GR3027558T3 (en) 1998-11-30
PE8697A1 (es) 1997-03-26
EP0770070A1 (fr) 1997-05-02
ZA955646B (en) 1996-02-21
RU2126397C1 (ru) 1999-02-20
EP0770070B1 (fr) 1998-09-30
CA2193531A1 (fr) 1996-01-25
IS2032B (is) 2005-08-15
NO970007L (no) 1997-01-02
PL318195A1 (en) 1997-05-26
US6022985A (en) 2000-02-08
NO314500B1 (no) 2003-03-31
TW419473B (en) 2001-01-21
HU220634B1 (hu) 2002-03-28
SK697A3 (en) 1997-06-04
NZ289455A (en) 1997-12-19
HUT76833A (en) 1997-11-28
FR2722191B1 (fr) 1996-08-23
CZ284695B6 (cs) 1999-02-17
SI0770070T1 (en) 1998-12-31
IS4411A (is) 1997-01-07
DE69505128D1 (de) 1998-11-05

Similar Documents

Publication Publication Date Title
FR2722191B1 (fr) Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
RU97101875A (ru) СПОСОБ ПОЛУЧЕНИЯ ТРИГИДРАТА (2R,3S)-3-ТРЕТ-БУТОКСИКАРБОНИЛАМИНО-2-ГИДРОКСИ-3- ФЕНИЛПРОПИОНАТА 4-АЦЕТОКСИ-2α-БЕНЗОИЛОКСИ-5β,,20-ЭПОКСИ- 1,7β,,10β-ТРИГИДРОКСИ-9-ОКСО-ТАКС-11-ЕН-13α-ИЛА
EP0823475A4 (en) HIGH UNSATURATED FATTY ACID PRODUCING MICROORGANISMS AND METHOD FOR PRODUCING HIGH UNSATURATED FATTY ACIDS BY USING THESE MICROORGANISMS
ATE112252T1 (de) Verfahren zur herstellung von fettalkoholen.
DK0515460T3 (da) Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme
SE7908516L (sv) Sett att framstella ett bakteriostatiskt material
FR2456116A1 (fr) Nouvelle saponine triterpenique derivee de la caulophyllogenine et ses applications therapeutiques
DE69009451D1 (de) Verfahren zur Dehydrierung eines fetthaltigen Produktes.
FR2751330B1 (fr) Procede de production de derivees de diol-1,3 naturels et de derives de 1,3-dioxane naturels correspondants
ES2120055T3 (es) Procedimiento para la obtencion biotecnologica de alcoholes, aldehidos y acidos carboxilicos.
JPS57145896A (en) Glycolipid and its preparation by fermentation
PL310207A1 (en) Nisatidin containing pharmaceutical agent, method of obtaining nisatidin in its specific form and specific form of nisatidin as such
JPS52109508A (en) Production of oil cake
FR2601386B1 (fr) Procede de bioconversion selective du dinitrate d'isosorbitol
TH20161A (th) ????????????????? 4-??????????-2?????-?????????????-5????, 20-????????-1, 7????, 10????-???????????-9-?????-??????-11-????-13?????-??? (2r, 3s)-3-???????-????????-???????????????-2-????????-3-???????????????? ?????????
JPS54144319A (en) Novel aminoglucopyranoside derivative its preparation, and oncostatic drugs comprising it as active constituent
HUT64291A (en) Method for racemizing non-racemic 3-oxo-cyclopentane-carboxylic acid or 3-oxo-cyclohexanecarboxylic acid, as well as their esters produced with alkohols containing 1 to 6 carbon atoms
ES8101548A1 (es) Procedimiento de obtencion de un derivado de prolina
JPS5569597A (en) Peptide derivative and its preparation
JPS5692794A (en) Preparation of l-glutamic acid by fermentation method
CO4810227A1 (es) Dihidrato de (2h,3s)-3-tert-butoxicarbonilamino-2-hidroxi- 3-fenilpropionato de 4,10beta-diacetoxi-2alfa-benzoiloxi-5, beta, 20-epoxi-1-hidroxi-9-oxo-19-norciclopropa[g] tax-11- eno-13alfa-ilo, y su proceso de preparacion
EP0345719A3 (en) Compounds containing at least three functional ester groups, and process for their preparation
BE873474A (fr) Procede de traitement de produits de deshydratation d'alcool alpha-methylbenzilique
KR930011875A (ko) 과포화 글루타민산 나트륨 용액의 제조 방법
RU92004454A (ru) Способ получения алкиладипатов